These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8499020)

  • 1. Enhancement of complement-mediated killing of Neisseria gonorrhoeae by antibodies to lipopolysaccharide of Escherichia coli J5.
    Appelmelk BJ; Verweij-van Vught M; Maaskant JJ; Thijs BG; Maclaren DM
    J Infect Dis; 1993 Mar; 167(3):773-5. PubMed ID: 8499020
    [No Abstract]   [Full Text] [Related]  

  • 2. Human vaccination with Escherichia coli J5 mutant induces cross-reactive bactericidal antibody against Neisseria gonorrhoeae lipooligosaccharide.
    Dale PA; McQuillen DP; Gulati S; Rice PA
    J Infect Dis; 1992 Aug; 166(2):316-25. PubMed ID: 1378871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-Dependent Serum Bactericidal Assays for Neisseria gonorrhoeae.
    Gulati S; Rice PA; Ram S
    Methods Mol Biol; 2019; 1997():267-280. PubMed ID: 31119629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection.
    Parzych EM; Gulati S; Zheng B; Bah MA; Elliott STC; Chu JD; Nowak N; Reed GW; Beurskens FJ; Schuurman J; Rice PA; Weiner DB; Ram S
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of magnesium in the enzyme-linked immunosorbent assay for lipopolysaccharides of rough Escherichia coli strain J5 and Neisseria gonorrhoeae.
    Ito JI; Wunderlich AC; Lyons J; Davis CE; Guiney DG; Braude AI
    J Infect Dis; 1980 Oct; 142(4):532-7. PubMed ID: 6777436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activating and opsonic capacity of monoclonal antibodies raised against Escherichia coli O111 and its rough mutant J5.
    Vreede RW; Leuvenink J; Bouter AS; Brouwer EC; Marcelis JH; Verhoef J
    Eur J Clin Microbiol; 1986 Apr; 5(2):141-7. PubMed ID: 3522225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
    Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
    J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against infection with Neisseria gonorrhoeae by immunization with outer membrane protein complex and purified pili.
    Buchanan TM; Pearce WA; Schoolnik GK; Arko RJ
    J Infect Dis; 1977 Aug; 136 Suppl():S132-7. PubMed ID: 408428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical specificity of cross-reactive antibodies to lipopolysaccharide from Escherichia coli J5.
    Schwartzer TA; Alcid DV; Numsuwan V; Gocke DJ
    J Infect Dis; 1987 May; 155(5):1076. PubMed ID: 3549920
    [No Abstract]   [Full Text] [Related]  

  • 10. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.
    Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS
    J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactivity of antibodies to lipopolysaccharides from Escherichia coli J5.
    Appelmelk BJ; Verweij-van Vught AM; Maaskant JJ; Thijs LG; MacLaren DM
    J Infect Dis; 1986 Sep; 154(3):538-9. PubMed ID: 3525700
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.
    Humbert MV; Christodoulides M
    Vaccine; 2018 Jun; 36(27):3926-3936. PubMed ID: 29803329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae.
    Densen P
    Clin Microbiol Rev; 1989 Apr; 2 Suppl(Suppl):S11-7. PubMed ID: 2497954
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunogenicity of Neisseria gonorrhoeae lipooligosaccharide epitope 2C7, widely expressed in vivo with no immunochemical similarity to human glycosphingolipids.
    Gulati S; McQuillen DP; Mandrell RE; Jani DB; Rice PA
    J Infect Dis; 1996 Dec; 174(6):1223-37. PubMed ID: 8940213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies specific for Escherichia coli J5 lipopolysaccharide: cross-reaction with other gram-negative bacterial species.
    Mutharia LM; Crockford G; Bogard WC; Hancock RE
    Infect Immun; 1984 Sep; 45(3):631-6. PubMed ID: 6381310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo.
    Kim KS; Kang JH; Cross AS; Kaufman B; Zollinger W; Sadoff J
    J Infect Dis; 1988 Jan; 157(1):47-53. PubMed ID: 2447199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of bacterial resistance to complement-mediated killing and on the mechanism of action of bactericidal antibody.
    Joiner KA
    Curr Top Microbiol Immunol; 1985; 121():99-133. PubMed ID: 3910367
    [No Abstract]   [Full Text] [Related]  

  • 18. Absence of bactericidal antibodies against Group-I lipopolysaccharide determinants of Neisseria gonorrhoeae during human infection.
    Blackwell CC; Winstanley FP; Weir DM; Kinane DF
    J Med Microbiol; 1984 Jun; 17(3):353-6. PubMed ID: 6427466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental immunization with a monoclonal anti-idiotope antibody that mimics the Neisseria gonorrhoeae lipooligosaccharide epitope 2C7.
    Gulati S; McQuillen DP; Sharon J; Rice PA
    J Infect Dis; 1996 Dec; 174(6):1238-48. PubMed ID: 8940214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonococcal infection: a model of molecular pathogenesis.
    Britigan BE; Cohen MS; Sparling PF
    N Engl J Med; 1985 Jun; 312(26):1683-94. PubMed ID: 2860565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.